Trial intelligence / Profile preview

Phase 3 trial of HP802-247 for chronic venous leg ulcers

2012-003286-18Phase 3Terminated

Sponsor
Smith & Nephew
Start
Jun 2013
Modality
Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of HP-802-247 in stasis ulcer, leg ulcer, sponsored by Smith & Nephew. Started Jun 2013; status: terminated.

02

Drugs

HP-802-247
03

Conditions

stasis ulcerleg ulcer

Beyond the preview

Go deeper on 2012-003286-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003286-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call